|
Week - 1 |
Upstream Process |
|
Week - 2 |
Cell Banks |
|
Week - 3 |
Master Cell Bank (MCB) |
|
Week - 4 |
Working Cell Bank (WCB) |
|
Week - 5 |
End of Production Cells (EOPC) |
|
Week - 6 |
Viability, Stability, Purity of Cell Banks |
|
Week - 7 |
Scale-up for Commercial Product Development |
|
Week - 8 |
Large Scale Fermentation Processes |
|
Week - 9 |
Fermentors and Bioreactors |
|
Week - 10 |
Downstream Process |
|
Week - 11 |
İnitial Product Recovery, Cell Disruption and Removal of Nucleic Acids
|
|
Week - 12 |
Initial Product Concentration |
|
Week - 13 |
Analytical Characterization of Therapeutic Protein |
|
Week - 14 |
Purification of Recombinant Therapeutic Protein |
Anadolu Info Package 
Turkish 
English